Clinical case of diagnosis of generalized tuberculosis in a child with a positive result of an intradermal test

At present day, generalized forms are rarely found in the structure of tuberculosis in children. A significant risk factor for the development of generalized lesions is prolonged contact with a tuberculosis patient. The diagnosis of a specific etiology is often complicated by the absence of pathognomonic symptoms. Immunodiagnostics, microbiological and molecular genetic research play an important role in the diagnosis of tuberculosis infection in children. The purpose of this study was to analyze the case of the development and diagnosis of generalized tuberculosis in a child of primary school age (7 years and 11 months) with lesions of the lungs, larynx, middle ear. The examination methods included immunological intradermal tests (Mantoux test, RTA test), in vitro test (QuantiFERON-TB), multispiral computed tomography, bronchoscopy and laboratory methods of examination. The manifestation of the disease occurred gradually with the occurrence of hypochromic anemia with a further increase in symptoms of intoxication. A comprehensive examination established a disseminated process in the lungs, larynx and middle ear lesions. Family tuberculosis contact was established when the disease was detected in a child. During the examination, the evaluation result of the Mantoux test showed an increase in sensitivity to tuberculin. The hyperergic result of the RTA test indicated the activity of MBT in the body. At the same time, the irregular conduct of immunodiagnostics using the Mantoux test, the monotony of the test did not allow timely measures to be taken in relation to the in-depth examination of the child for tuberculosis. The specific etiology of the disease was reliably confirmed by cultural and molecular genetic research methods. The child was diagnosed with generalized tuberculosis, disseminated pulmonary tuberculosis in the infiltration phase, MBT (+) with drug resistance to isoniazid, streptomycin, paraaminosalicylic acid, tuberculosis of the larynx and vocal apparatus, PCR (+) with drug resistance to isoniazid, tuberculous right-sided otitis media, MBT (+) with drug resistance to isoniazid, streptomycin, paraaminosalicylic acid. The presented clinical case indicates the need for timely detection of tuberculosis contacts, regular immunodiagnostics, and compliance with phthisiological alertness of doctors of all specialties in relation to children with long-lasting symptoms of various diseases. The complete physical examination using an intradermal RTA test (Diaskintest), microbiological and molecular genetic research methods allows to establish the tuberculous etiology of the lesion.

1. Aksenova V.A., Gordina A.V. Issues on tuberculosis among children and adolescents in Russian Federation. Pacific Medical Journal. 2021;(1):80-84. (In Russ.) Available at: https://www.tmj-vgmu.ru/jour/article/view/2170.

2. Aksenova V.A., Sterlikov S.A., Kucheryavaya D.A., Gordina A.V., Pankova Ya.Yu., Vasilyeva I.A. Tuberculosis situation in children in 2021 and the prospects of its change in 2022. Tuberculosis and Lung Diseases. 2022;100(11):13-19. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-11-13-19.

3. Nechaeva O.B. Tuberculosis in children in Russia. Tuberculosis and Lung Diseases. 2020;98(11):12-20. (In Russ.) https//doi.org/10.21292/2075-1230-2020-98-11-12-20.

4. Slogotskaya L.V., Bogorodskaya E.M., Shamuratova L.F., Sevostyanova T.A. Efficiency of screening for tuberculosis infection in children and adolescents in Moscow in 2019 based on the new procedure for using the intradermal test with tuberculosis recombinant allergen (ESAT-6/CFP-10). Tuberculosis and Lung Diseases. 2021;99(1):15-25. (In Russ.) https://doi.org/10.21292/2075-1230-2021-99-1-15-25.

5. Esposito S., Tagliabue C., Bosis S. Tuberculosis in children. Mediterr J Hematol Infect Dis. 2013;5(1):e2013064. https://doi.org/10.4084/MJHID.2013.064.

6. Bykov I.A. Social and demographic factors contributing to the spread of multiple drug resistant tuberculosis in the Russian Federation: a systematic review. Tuberculosis and Lung Diseases. 2022;100(6):59-65. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-6-59-65.

7. Lozovskaya M.E., Klochkova L.V., Vasilyeva E.B., Mosina A.V., Yarovaya Yu.A., Noskova O.M. Tuberculosis in young children. Pediatrician (St Petersburg). 2017;8(S1):194-195. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=29329542.

8. Pravada N.S., Budritskiy A.M., Seregina V.A. The peculiarities of detection and diagnosis of tuberculosis in children and adolescents. Vestnik of Vitebsk State Medical University. 2021;20(3):40-45. (In Russ.) https://doi.org/10.22263/2312-4156.2021.3.40.

9. Perelman M.I. (ed.). Phthisiology. National leadership. Moscow: GEOTAR-Media; 2007. 512 p. (In Russ.)

10. Porkulevich N.I., Ashenova G.Zh., Leontieva E.S. Clinical manifestations of extrapulmonary and generalized tuberculosis in children. Ural Medical Journal. 2018;(8):83-88. (In Russ.) Available at: https://elibrary.ru/item.asp?id=36369986.

11. Roya-Pabon C.L., Perez-Velez C.M. Tuberculosis exposure, infection and disease in children: a systematic diagnostic approach. Pneumonia (Nathan). 2016;8:23. https://doi.org/10.1186/s41479-016-0023-9.

12. Aksenova V.A., Baryshnikova L.A., Dolzhenko E.N., Kudlay D.A. Tuberculosis screening in children today: important issues. Doctor.Ru. 2012;(8):27-29. (In Russ.) Available at: https://elibrary.ru/item.asp?id=18286404.

13. Aksenova V.A., Baryshnikova L.A., Klevno N.I., Kudlay D.A. Screening for tuberculosis infection in children and adolescents in Russia - past, present, future. Tuberculosis and Lung Diseases. 2019;97(9):59-67. (In Russ.) https://doi.org/10.21292/2075-1230-2019-97-9-59-67.

14. Krivokhizh V.N., Stepanov G.A. Diagnosis and treatment of latent tuberculosis infection (LTI) in children and adolescents. Pediatrician (St Petersburg). 2017;8(S1):M166. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=30719015.

15. Lozovskaya M.E., Yarovaya Yu.A., Shumilova Yu.R., Vasilyeva E.B., Nikiforenko N.A., Klochkova L.V. Clinical and epidemiological significance of inversion of the skin test with recombinant tuberculosis allergen in children. Vestnik of Novgorod State University. Series: Medical Sciences. 2022;(4):35-41. (In Russ.) https://doi.org/10.34680/2076-8052.2022.4(129).35-41.

16. Slogotskaya L.V., Litvinov V., Ovsyankina E., Seltsovsky P., Kudlay D. Results of QuantiFERON-TB Gold in-tube and skin testing with recombinant proteins CFP-10-ESAT-6 in children and adolescents with TB or latent TB infection. Paediatr Respir Rev. 2013;14(Suppl. 2):S65. https://doi.org/10.1016/S1526-0542(13)70092-7.

17. Slogotskaya L.V., Litvinov V., Kudlay D.A., Ovsyankina E., Seltsovsky P., Ivanova D., Nikolenko N. New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection. Eur Respir J. 2012;40(Suppl. 56):416. Available at: https://erj.ersjournals.com/content/40/Suppl_56/P416.

18. Bogorodskaya E.M. The impact of the COVID-19 pandemic on the organization of TB care in the city of Moscow. Tuberculosis and Socially Significant Diseases. 2020;(4):3-9. (In Russ.) Available at: http://tb-journal.ru/wp-content/uploads/2022/08/001_0420tb.pdf.